| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
254,036,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$22.93 - $22.93 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Halstead Michael |
Senior V.P., Corp. Development |
• – – |
2012-01-30 |
4 |
S |
$16.45 |
$5,265 |
D/D |
(320) |
21,484 |
|
- |
|
| Van Zoonen Marinus Johannes |
President, Europe/Intl & Mkt. |
• – – |
2012-01-30 |
4 |
S |
$16.45 |
$36,441 |
D/D |
(2,215) |
38,699 |
|
- |
|
| Herendeen Paul |
Exec. V.P. and CFO |
• – – |
2012-01-30 |
4 |
S |
$16.45 |
$35,980 |
D/D |
(2,187) |
365,376 |
|
- |
|
| Hara Izumi |
Sr. VP, Gen. Counsel & Sec. |
• – – |
2012-01-23 |
4 |
S |
$17.32 |
$20,246 |
D/D |
(1,169) |
182,185 |
|
- |
|
| Gilligan Claire A |
Senior V.P., Quality |
• – – |
2012-01-23 |
4 |
S |
$17.32 |
$16,159 |
D/D |
(933) |
50,333 |
|
- |
|
| Howard Alvin D |
Sr. V.P., Regulatory Affairs |
• – – |
2012-01-23 |
4 |
S |
$17.32 |
$21,216 |
D/D |
(1,225) |
218,427 |
|
- |
|
| Fuhrmann Rochelle |
Senior V.P., Finance |
• – – |
2012-01-23 |
4 |
S |
$17.32 |
$8,435 |
D/D |
(487) |
26,292 |
|
- |
|
| Halstead Michael |
Senior V.P., Corp. Development |
• – – |
2012-01-23 |
4 |
S |
$17.32 |
$8,435 |
D/D |
(487) |
21,804 |
|
- |
|
| Ellman Herman |
Senior V.P., Clinical Devel. |
• – – |
2012-01-23 |
4 |
S |
$17.32 |
$20,246 |
D/D |
(1,169) |
174,838 |
|
- |
|
| Herendeen Paul |
Exec. V.P. and CFO |
• – – |
2012-01-23 |
4 |
S |
$17.32 |
$71,859 |
D/D |
(4,149) |
367,563 |
|
- |
|
| Boissonneault Roger M |
CEO & President |
• • – |
2012-01-23 |
4 |
S |
$17.32 |
$236,446 |
D/D |
(13,652) |
2,103,980 |
|
- |
|
| Howard Alvin D |
Sr. V.P., Regulatory Affairs |
• – – |
2012-01-11 |
4 |
S |
$16.66 |
$19,093 |
D/D |
(1,146) |
219,652 |
|
- |
|
| Fuhrmann Rochelle |
Senior V.P., Finance |
• – – |
2012-01-11 |
4 |
S |
$16.66 |
$6,847 |
D/D |
(411) |
26,779 |
|
- |
|
| Ellman Herman |
Senior V.P., Clinical Devel. |
• – – |
2012-01-11 |
4 |
S |
$16.66 |
$17,360 |
D/D |
(1,042) |
176,007 |
|
- |
|
| Halstead Michael |
Senior V.P., Corp. Development |
• – – |
2012-01-11 |
4 |
S |
$16.66 |
$7,531 |
D/D |
(452) |
22,291 |
|
- |
|
| Fenton Andrew |
Senior V.P., CIO |
• – – |
2012-01-11 |
4 |
S |
$16.66 |
$9,297 |
D/D |
(558) |
77,594 |
|
- |
|
| Cross Leland H |
Senior V.P., Tech. Operations |
• – – |
2012-01-11 |
4 |
S |
$16.66 |
$15,128 |
D/D |
(908) |
175,128 |
|
- |
|
| Hara Izumi |
Sr. VP, Gen. Counsel & Sec. |
• – – |
2012-01-11 |
4 |
S |
$16.66 |
$18,243 |
D/D |
(1,095) |
183,354 |
|
- |
|
| Fenton Andrew |
Senior V.P., CIOOfficer |
• – – |
2012-01-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
78,152 |
|
- |
|
| Reichel W Carl |
President, Pharmaceuticals |
• – – |
2011-12-31 |
4 |
D |
$0.00 |
$0 |
D/D |
(61,512) |
310,082 |
|
- |
|
| Fawzi Mahdi B |
President, Research & Develop. |
• – – |
2011-10-21 |
4 |
S |
$16.80 |
$40,623 |
D/D |
(2,418) |
57,755 |
|
- |
|
| Halstead Michael |
Senior V.P., Corp. Development |
• – – |
2011-06-30 |
4 |
A |
$0.00 |
$0 |
D/D |
7,460 |
22,821 |
|
- |
|
| Cross Leland H |
Senior V.P., Tech. Operations |
• – – |
2011-06-10 |
4 |
S |
$22.29 |
$1,773,746 |
D/D |
(79,563) |
176,036 |
|
- |
|
| Cross Leland H |
Senior V.P., Tech. Operations |
• – – |
2011-06-09 |
4 |
S |
$22.41 |
$2,241,010 |
D/D |
(100,000) |
255,599 |
|
- |
|
| Halstead Michael |
Senior V.P., Corp. Development |
• – – |
2011-06-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
15,361 |
|
- |
|
380 Records found
|
|
Page 7 of 16 |
|
|
